drugset

drugset / Trial / NCT02477150

Safety and Immunogenicity of a Zoster Vaccine in SLE

NCT02477150 ↗

Phase 4 Completed 90 enrolled Tuen Mun Hospital

RandomizedParallel-groupDouble-blindPrevention

Summary

To study the safety and immunogenicity of a herpes zoster vaccine in patients with SLE.

Timeline

Start: 2015-11
Primary completion: 2018-11
Completion: 2019-01

Publications

Mok CC, Chan KH, Ho LY, Fung YF, Fung WF, Woo PCY. Safety and immune response of a live-attenuated herpes zoster vaccine in patients with systemic lupus erythematosus: a randomised placebo-controlled trial. Ann Rheum Dis. 2019 Dec;78(12):1663-1668. doi: 10.1136/annrheumdis-2019-215925. Epub 2019 Sep 17.

Drugs

Evaluation	Drug	Modality	Dose	Route
Comparator	Varivax	Vaccine	0.65 ml	Subcutaneous

Indications